|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-12-14
|
|
pubmed:abstractText |
To compare the effects of low-dose transdermal estradiol (E2)/norethisterone acetate (NETA) patches (Estalis 25/125) with low-dose oral E2/NETA (Activelle) on cardiovascular biochemical markers after 12 and 52 weeks of treatment in postmenopausal women with intact uteri.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1072-3714
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
978-84
|
|
pubmed:meshHeading |
pubmed-meshheading:17595593-Administration, Cutaneous,
pubmed-meshheading:17595593-Administration, Oral,
pubmed-meshheading:17595593-Biological Markers,
pubmed-meshheading:17595593-Cardiovascular Diseases,
pubmed-meshheading:17595593-Double-Blind Method,
pubmed-meshheading:17595593-Endometrium,
pubmed-meshheading:17595593-Endothelium, Vascular,
pubmed-meshheading:17595593-Estradiol,
pubmed-meshheading:17595593-Estrogen Replacement Therapy,
pubmed-meshheading:17595593-Female,
pubmed-meshheading:17595593-Humans,
pubmed-meshheading:17595593-Middle Aged,
pubmed-meshheading:17595593-Norethindrone,
pubmed-meshheading:17595593-Postmenopause,
pubmed-meshheading:17595593-Switzerland,
pubmed-meshheading:17595593-Treatment Outcome
|
|
pubmed:articleTitle |
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
|
|
pubmed:affiliation |
Department of Endocrinology and Menopause, University Women's Hospital, Tübingen, Germany. endo.meno@med.uni-uebingen.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
